Evidence map›Paper›PMID 42301443›Full record

ArticleSurgical endoscopy2026

Optimizing risk cutoffs in joint endoscopic screening for upper gastrointestinal cancers: a data-driven approach from models to real-world practice.

Dongze Chen, Zhen Liu, Mengfei Liu, Chuanhai Guo, Yujie He, Fenglei Li, Yun Chen, Ping Xiao, Ping Ji, Zhengyu Fang and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Dongze ChenKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genetics, Peking University Cancer Hospital & Institute, Beijing, China.
Zhen LiuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genetics, Peking University Cancer Hospital & Institute, Beijing, China.
Mengfei LiuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genetics, Peking University Cancer Hospital & Institute, Beijing, China.
Chuanhai GuoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genetics, Peking University Cancer Hospital & Institute, Beijing, China.
Yujie HeEndoscopy Center, Hua County People's Hospital, Anyang, 456483, Henan, China.
Fenglei LiHua County People's Hospital, Anyang, 456483, Henan, China.
Yun ChenDepartment of Ultrasound, Peking University Shenzhen Hospital, Shenzhen, 516473, Guangdong, China.
Ping XiaoClinical Research Institute, Shenzhen Peking University-Hong Kong University of Science and Technology Medical Center, Shenzhen, 516473, Guangdong, China.
Ping JiClinical Research Institute, Shenzhen Peking University-Hong Kong University of Science and Technology Medical Center, Shenzhen, 516473, Guangdong, China.
Zhengyu FangClinical Research Institute, Shenzhen Peking University-Hong Kong University of Science and Technology Medical Center, Shenzhen, 516473, Guangdong, China.
Shengjuan HuDepartment of Gastroenterology, Endoscopic Center, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, 750001, China.
Chao ShiNingxia Clinical Research Institute, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, 750001, China.
Yaqi PanKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genetics, Peking University Cancer Hospital & Institute, Beijing, China.
Zhonghu HeState Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Genetics, Peking University Cancer Hospital & Institute, Beijing, China. zhonghuhe@foxmail.com.ORCID http://orcid.org/0000-0002-4444-7950
Yang KeState Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Genetics, Peking University Cancer Hospital & Institute, Beijing, China. keyang@bjmu.edu.cn.

Funding

Key R&D Program of Ningxia Hui Autonomous Region 2025BEG01011Science and Technology Planning Project of Tibet Autonomous Region XZ202501JD0021
6 · The paper itself

Abstract

backgroundAlthough risk prediction models for esophageal cancer (EC) and gastric cancer (GC) exist, determining appropriate cutoffs under predetermined endoscopy capacity remains challenging. We aimed to develop a strategy for selecting optimal high-risk cutoffs in model-based joint screening for EC and GC.

methodsWe built and validated the strategy based on four population-based screening cohorts from different regions of China and two diagnostic models for predicting prevalent EC and GC. The proposed strategy consisted of two steps: determining the relative high-risk coverage depending on the incidence rate ratio (IRR) of EC to GC and identifying the optimal cutoffs through an exhaustive search approach.

resultsTotally, 43,156 individuals who had undergone endoscopic examination were included in the analysis. Taking two opportunistic screening cohorts as a benchmark dataset, we built the strategy for selecting optimal cutoffs for EC and GC at an expected total high-risk coverage of 50%. The results showed that under different IRR scenarios (range: 0.2-5.0), the optimal cutoffs could be identified by this strategy to achieve a total high-risk coverage of 50% and the detection rates of both EC and GC were improved (detection rate ratios range: 1.72-5.77). External validation results indicated that the high-risk cutoffs determined by this strategy are applicable to other populations. Finally, we developed a user-friendly online tool to aid cutoff selection ( https://pkucr.shinyapps.io/cutoff_selection/ ).

conclusionsThis study provided a strategy for the selection of high-risk cutoffs in EC and GC joint screening, which may hold promise for advancements in model-based joint screening.

Indexed as

Early Detection of CancerEndoscopy, GastrointestinalEsophageal NeoplasmsStomach NeoplasmsChinaFemaleHumansMaleRisk AssessmentHigh-risk cutoffsJoint screeningModel-based risk assessmentUpper gastrointestinal cancers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.